Eric Deneault is a research scientist at Health Canada, leading the Advanced Cell and Gene Therapy laboratory. He received his BSc in biotechnology from the University of Sherbrooke, Canada, and he obtained his MSc in veterinary sciences and a PhD in molecular biology from the University of Montreal. He then joined the Hospital for Sick Children, Toronto, Canada as a postdoctoral researcher in genetics. In his current research, he is using induced pluripotent stem cells and CRISPR gene-editing techniques as a model to support regulatory research in cell and gene therapies.
Eric Deneault is a research scientist at Health Canada, leading the Advanced Cell and Gene Therapy laboratory. He received his BSc in biotechnology from the University of Sherbrooke, Canada, and he obtained his MSc in veterinary sciences and a PhD in molecular biology from the University of Montreal. He then joined the Hospital for Sick Children, Toronto, Canada as a postdoctoral researcher in genetics. In his current research, he is using induced pluripotent stem cells and CRISPR gene-editing techniques as a model to support regulatory research in cell and gene therapies.